EcoDrugPlus

Ribosomal Protein L31

Ensembl ID : ENSCSEG00000010181
Gene Symbol: RPL31
3 Cross references
650 Possible Orthologues:

Ribosomal Protein L34

Ensembl ID : ENSCSEG00000007122
Gene Symbol: RPL34
1 Cross references
285 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSCSEG00000001073
Gene Symbol: RPL35
1 Cross references
176 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSCSEG00000006207
Gene Symbol: RPL35A
3 Cross references
512 Possible Orthologues:

Ribosomal Protein L36

Ensembl ID : ENSCSEG00000019593
Gene Symbol: RPL36
3 Cross references
407 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSCSEG00000001286
Gene Symbol: RPL37
3 Cross references
431 Possible Orthologues:

Ribosomal Protein L37a

Ensembl ID : ENSCSEG00000008838
Gene Symbol: RPL37A
4 Cross references
455 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSCSEG00000013755
Gene Symbol: RPL38
3 Cross references
235 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSCSEG00000002037
Gene Symbol: RPL39
1 Cross references
571 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSCSEG00000017733
Gene Symbol: RPL5
4 Cross references
452 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSCSEG00000012238
Gene Symbol: RPL6
1 Cross references
486 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSCSEG00000019765
Gene Symbol: RPL6
1 Cross references
486 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).